Cancer risk stratification company PreciseDx, a Mount Sinai Health System spin-off,has developed artificial intelligence-enabled digital pathology technologyto detect Parkinson’s disease (PD), and new research conducted in collaboration with the Michael J. Fox Foundation (M...